Incidence of Burkitt lymphoma in the United States during 2000 to 2019

Burkitt lymphoma (BL) is an aggressive B‐cell lymphoma that occurs worldwide. A study of BL in the US National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program during 1973 to 2005 (n = 3043) revealed three age‐specific incidence peaks of BL and rates that were rising. We studied BL cases diagnosed in SEER 22 during 2000 to 2019 (n = 11 626) to investigate age‐specific BL incidence rates and temporal trends. The age‐standardized BL incidence rate was 3.96/million person‐years, with a 2.85:1 male‐to‐female ratio. The BL rate among both Hispanic and White individuals was higher than in Black individuals (4.52, 4.12 vs 3.14). Age‐specific BL rates showed peaks during pediatric, adult and elderly years in males and pediatric and elderly peaks in females. Based on 4524 BL cases with HIV status (SEER 13), only one peak in adult males (45 years) was observed. Overall age‐standardized BL incidence rates rose 1.2%/year (not significant) up to 2009 then fell significantly by 2.4%/year thereafter. Temporal trends in BL rates during 2000 to 2019 varied with age group as pediatric BL rates rose 1.1%/year, while elderly BL rates fell 1.7%/year and adult BL rates rose 3.4%/year until 2007 before falling 3.1%/year thereafter. Overall survival from BL was 64% at 2 years, being highest in pediatric patients and lowest in Black and elderly individuals vs other subgroups. Survival improved by 20% between 2000 and 2019. Our data suggest that BL age‐specific incidence rates are multimodal and that overall BL rates rose up to 2009 and then fell, suggesting changes in etiological factors or diagnosis.

[1]  C. López,et al.  Burkitt lymphoma , 2022, Nature reviews. Disease primers.

[2]  H. Balfour,et al.  Declining Epstein-Barr Virus Antibody Prevalence in College Freshmen Strengthens the Rationale for a Prophylactic EBV Vaccine , 2022, Vaccines.

[3]  S. Devesa,et al.  Burkitt Lymphoma Incidence in Five Continents , 2022, Hemato.

[4]  A. Rosenwald,et al.  The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms , 2022, Leukemia.

[5]  Ryan D. Morin,et al.  Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma , 2021, medRxiv.

[6]  R. Spang,et al.  Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features , 2021, British journal of haematology.

[7]  P. Sullivan,et al.  Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses , 2021, The Lancet.

[8]  Sunjai Gupta,et al.  Evaluating case studies of community-oriented integrated care , 2018, London journal of primary care.

[9]  W. Anderson,et al.  Age‐related heterogeneity of Burkitt lymphoma , 2018, British journal of haematology.

[10]  Andrew J. Dunford,et al.  Tumor suppressor genes that escape from X-inactivation contribute to cancer sex bias , 2016, Nature Genetics.

[11]  S. Swerdlow,et al.  Natural killer cell (NK) subsets and NK‐like T‐cell populations in acute myeloid leukemias and myelodysplastic syndromes , 2016, Cytometry. Part B, Clinical cytometry.

[12]  Shuangge Ma,et al.  Racial differences in three major NHL subtypes: descriptive epidemiology. , 2015, Cancer epidemiology.

[13]  B. Nathwani,et al.  Epstein–Barr virus patterns in US Burkitt lymphoma tumors from the SEER residual tissue repository during 1979–2009 , 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  H. Balfour,et al.  Age-specific prevalence of Epstein-Barr virus infection among individuals aged 6-19 years in the United States and factors affecting its acquisition. , 2013, The Journal of infectious diseases.

[15]  D. Weisenburger,et al.  Burkitt lymphoma risk in U.S. solid organ transplant recipients , 2013, American journal of hematology.

[16]  J. Ferlay,et al.  Pediatric, elderly, and emerging adult‐onset peaks in Burkitt's lymphoma incidence diagnosed in four continents, excluding Africa , 2012, American journal of hematology.

[17]  E. Simard,et al.  AIDS-related Burkitt lymphoma in the United States: what do age and CD4 lymphocyte patterns tell us about etiology and/or biology? , 2010, Blood.

[18]  P. Rosenberg,et al.  Trimodal age‐specific incidence patterns for Burkitt lymphoma in the United States, 1973–2005 , 2010, International journal of cancer.

[19]  C. Bellan,et al.  Burkitt lymphoma versus diffuse large B‐cell lymphoma: a practical approach , 2009, Hematological oncology.

[20]  S. Devesa,et al.  Sporadic childhood Burkitt lymphoma incidence in the United States during 1992–2005 , 2009, Pediatric blood & cancer.

[21]  L. Ries,et al.  Cancer Incidence, Mortality, and Patient Survival in the United States , 2006 .

[22]  Richard Simon,et al.  Molecular diagnosis of Burkitt's lymphoma. , 2006, The New England journal of medicine.

[23]  R. Spang,et al.  A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. , 2006, The New England journal of medicine.

[24]  J. Goedert,et al.  High levels of Epstein-Barr virus DNA in saliva and peripheral blood from Ugandan mother-child pairs. , 2006, The Journal of infectious diseases.

[25]  H. Müller-Hermelink,et al.  Clinical, Immunophenotypic, and Genetic Analysis of Adult Lymphomas With Morphologic Features of Burkitt Lymphoma , 2005, The American journal of surgical pathology.

[26]  A. Jemal,et al.  Trends in Kaposi's sarcoma and non-Hodgkin's lymphoma incidence in the United States from 1973 through 1998. , 2002, Journal of the National Cancer Institute.

[27]  G Flandrin,et al.  The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997. , 1999, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  D. Wright.  What is Burkitt's lymphoma and when is it endemic? , 1999, Blood.

[29]  T. Fears,et al.  Graphical presentation of trends in rates. , 1995, American journal of epidemiology.

[30]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[31]  John W. Ward,et al.  1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[32]  R. Berger,et al.  Cytogenetic studies on African Burkitt's lymphoma cell lines: t(8;14), t(2;8) and t(8;22) translocations. , 1981, Cancer genetics and cytogenetics.

[33]  A. Geser,et al.  The frequency of Epstein-Barr virus infection and Burkitt's lymphoma at high and low altitudes in East Africa. , 1980, Revue d'epidemiologie et de sante publique.

[34]  V. Devita,et al.  The American Burkitt Lymphoma Registry: a progress report. , 1975, Annals of internal medicine.

[35]  G. Manolov,et al.  Marker Band in One Chromosome 14 from Burkitt Lymphomas , 1972, Nature.

[36]  D. Burkitt.  Burkitt's lymphoma outside the known endemic areas of Africa and New Guinea , 1967, International journal of cancer.

[37]  D. Wright.  Burkitt's tumour in england a comparison with childhood lymphosarcoma , 1966, International journal of cancer.

[38]  R. Dorfman.  Childhood lymphosarcoma in St. Louis, Missouri, clinically and histologically resembling Burkitt's tumor , 1965, Cancer.

[39]  M. Epstein,et al.  CULTIVATION IN VITRO OF HUMAN LYMPHOBLASTS FROM BURKITT'S MALIGNANT LYMPHOMA. , 1964, Lancet.

[40]  J. Davies,et al.  Malignant tumors in African children. With special reference to malignant lymphoma. , 1960, The Journal of pediatrics.

[41]  D. Burkitt,et al.  A sarcoma involving the jaws in african children , 1958, CA: a cancer journal for clinicians.

[42]  B. Macmahon,et al.  Epidemiological evidence on the nature of hodgkin's disease , 1957 .

[43]  R. Advani,et al.  The World Health Organization Classification of Lymphoid Neoplasms , 2013 .

[44]  G. Klein,et al.  Burkitt lymphoma. , 2009, Seminars in cancer biology.

[45]  R. Connelly,et al.  Burkitt's lymphoma in the USA: cases reported to the American Burkitt Lymphoma Registry compared with population-based incidence and mortality data. , 1985, IARC scientific publications.

[46]  National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. , 1982, Cancer.